TrademarkDir
FLUENCY
LIVE

Serial Number

97602539

Owner

Immuneering Corporation

Attorney

Ian W. Gillies

First Use Date

Mar 10, 2022

Filing Date

Sep 22, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FLUENCY Trademark

Serial Number: 97602539 • Registration: 7508809

FLUENCY is a trademark filed by Immuneering Corporation on September 22, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Immuneering Corporation (7 trademarks)

Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

September 22, 2022

Registration Date

September 17, 2024

First Use Anywhere

March 10, 2022

First Use in Commerce

March 10, 2022

Published for Opposition

August 8, 2023

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 14, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 14, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 6, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 6, 2024 AITU
USE AMENDMENT FILED
May 28, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
May 28, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 2, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 2, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 2, 2024 EEXT
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2023 CNSA
ASSIGNED TO EXAMINER
Jul 5, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2022 NWOS
NEW APPLICATION ENTERED
Sep 26, 2022 NWAP

Related Trademarks

More from this Owner

DEEP CYCLIC INHIBITION

DEEP CYCLIC INHIBITION

DEEP CYCLIC INHIBITION

DEEP CYCLIC INHIBITION

ALLEO LABS

ALLEO LABS

DISEASE CANCELLING

DISEASE CANCELLING

DISEASE CANCELLING

DISEASE CANCELLING

DISEASE CANCELLING

DISEASE CANCELLING